ExLibris header image
SFX Logo
Title: Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
Source:

Nature Medicine [1078-8956] Whitson, Ramon yr:2018


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Wan, J. "Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas." Genes & Diseases (2019). Link to Full Text for this item Link to SFX for this item
2. Rudin, H. "Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma." Cancer cell 27.3 (2015): 327-341. Link to SFX for this item
3. Mandal, M. "Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas." Critical reviews in oncology/hematology 98 (2015): 235-41. Link to SFX for this item
4. Ransohoff, Katherine J. "Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma." Journal of clinical oncology 33.24 (2015): 2692-2694. Link to SFX for this item
5. Ransohoff, Katherine J. "Squamous Change in Basal-Cell Carcinoma with Drug Resistance." The New England journal of medicine 373.11 (2015): 1079-82. Link to SFX for this item
6. Atwood, Scott X. "Smoothened variants explain the majority of drug resistance in Basal cell carcinoma." Cancer cell 27.3 (2015): 342-53. Link to SFX for this item
7. JEON, Y. "Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies." Cancer cell 27.3 (2015): 354-369. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.